What is the cause of an eczematoid rash at intertriginous areas in patients receiving prolonged Total Parenteral Nutrition (TPN)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The correct answer is (b) fatty acid deficiency, as eczematoid rash in intertriginous areas is a characteristic manifestation of essential fatty acid deficiency in patients receiving prolonged total parenteral nutrition (TPN) without adequate lipid supplementation 1. This condition typically develops after 2-4 weeks of fat-free TPN. The rash appears as scaly, erythematous patches in skin fold areas and can progress to generalized dermatitis if untreated. Essential fatty acids, particularly linoleic and alpha-linolenic acids, are crucial for maintaining skin barrier function and preventing transepidermal water loss. They serve as precursors for eicosanoids that regulate inflammatory processes in the skin.

According to the ESPEN guidelines on parenteral nutrition, the nutritional requirements in patients on HPN should be based on a formal nutritional assessment, including disease-specific needs and factors such as medical condition, nutritional status, activity level, and fluid restrictions and organ function 1. However, the specific pattern of eczematoid rash in intertriginous areas is characteristic of fatty acid deficiency.

Key points to consider:

  • Essential fatty acids are crucial for maintaining skin barrier function and preventing transepidermal water loss
  • Fatty acid deficiency can cause dermatological manifestations during TPN
  • Treatment involves adding lipid emulsions to the TPN regimen, typically providing 2-4% of total calories as linoleic acid
  • Improvement in skin manifestations usually occurs within 1-2 weeks after initiating appropriate fatty acid supplementation.

From the Research

Eczematoid Rash at Intertriginous Areas with Prolonged Total Parenteral Nutrition

  • The condition is likely caused by a nutritional deficiency, with several studies suggesting that zinc deficiency is a common cause of skin lesions in patients on total parenteral nutrition (TPN) 2, 3, 4, 5.
  • Zinc deficiency can lead to a range of symptoms, including skin rash, impaired wound healing, and impaired immune function 2, 3, 5.
  • The incidence of zinc deficiency in patients on TPN can be increased due to factors such as inadequate zinc supplementation, gastrointestinal losses, and poor nutritional status 3, 5.
  • Other nutritional deficiencies, such as fatty acid deficiency, copper deficiency, magnesium deficiency, and niacin deficiency, can also cause skin lesions, but the evidence suggests that zinc deficiency is a more common cause of eczematoid rash at intertriginous areas in patients on TPN.
  • Intertrigo, a superficial inflammatory skin disorder, can also occur in intertriginous areas, but it is primarily caused by skin-on-skin friction and moisture, rather than nutritional deficiency 6.

Possible Causes

  • Zinc deficiency: supported by studies 2, 3, 4, 5
  • Fatty acid deficiency: not supported by the provided studies
  • Copper deficiency: not supported by the provided studies
  • Magnesium deficiency: not supported by the provided studies
  • Niacin deficiency: not supported by the provided studies

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Clinical zinc deficiency in total parenteral nutrition: zinc supplementation.

JPEN. Journal of parenteral and enteral nutrition, 1983

Research

Zinc: physiology, deficiency, and parenteral nutrition.

Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition, 2015

Research

Intertriginous eruption.

Clinics in dermatology, 2011

Related Questions

What is the cause of an eczematoid rash at intertriginous areas in patients receiving prolonged Total Parenteral Nutrition (TPN)?
What is the cause of alopecia in patients receiving prolonged Total Parenteral Nutrition (TPN), considering options such as zinc deficiency, magnesium deficiency, vitamin A intoxication, essential fatty acids deficiency, or selenium deficiency?
What is the treatment for intertriginous dermatitis under the breast area?
What is the treatment and management for intertrigo?
Can intertriginous ulcers be full thickness?
What is the most useful complementary method in diagnosing Multiple Sclerosis (MS)?
What is the term for the volume of air moved with maximum exhalation after deep inhalation, also known as Forced Vital Capacity (FVC) or Vital Capacity (VC)?
What is the cause of an eczematoid rash at intertriginous areas in patients receiving prolonged Total Parenteral Nutrition (TPN)?
What is the appropriate treatment approach for a patient with Human Immunodeficiency Virus (HIV) infection, not receiving Antiretroviral Therapy (ART), with a low CD4 count, presenting with miliary tuberculosis?
What is the use of Doxazosin (alpha-1 adrenergic blocker)?
What is the diagnosis and treatment for a 6-year-old patient presenting with a sore throat, body aches, painful swallowing, and nasal congestion, with an onset of symptoms 1 day ago, and no recent exposure to streptococcal pharyngitis or antibiotic use, accompanied by their mother and requiring a Certified Medical Assistant (CMA) Spanish translator?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.